BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

899 related articles for article (PubMed ID: 30691685)

  • 1. Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting.
    Talukdar S; Bhoopathi P; Emdad L; Das S; Sarkar D; Fisher PB
    Adv Cancer Res; 2019; 141():43-84. PubMed ID: 30691685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor dormancy and cancer stem cells: two sides of the same coin?
    Kleffel S; Schatton T
    Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dormant disseminated tumor cells and cancer stem/progenitor-like cells: Similarities and opportunities.
    Hen O; Barkan D
    Semin Cancer Biol; 2020 Feb; 60():157-165. PubMed ID: 31491559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor dormancy as an alternative step in the development of chemoresistance and metastasis - clinical implications.
    Rossari F; Zucchinetti C; Buda G; Orciuolo E
    Cell Oncol (Dordr); 2020 Apr; 43(2):155-176. PubMed ID: 31392521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Cancer Cell Dormancy.
    Recasens A; Munoz L
    Trends Pharmacol Sci; 2019 Feb; 40(2):128-141. PubMed ID: 30612715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epigenetic/noncoding origin of tumor dormancy.
    Crea F; Nur Saidy NR; Collins CC; Wang Y
    Trends Mol Med; 2015 Apr; 21(4):206-11. PubMed ID: 25771096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.
    Shiozawa Y; Berry JE; Eber MR; Jung Y; Yumoto K; Cackowski FC; Yoon HJ; Parsana P; Mehra R; Wang J; McGee S; Lee E; Nagrath S; Pienta KJ; Taichman RS
    Oncotarget; 2016 Jul; 7(27):41217-41232. PubMed ID: 27172799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell dormancy and tumor refractory.
    Wang K; Jiang W; Cheng C; Li Y; Tu M
    Anticancer Agents Med Chem; 2013 Feb; 13(2):1312-1316. PubMed ID: 22934702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor dormancy: long-term survival in a hostile environment.
    Quesnel B
    Adv Exp Med Biol; 2013; 734():181-200. PubMed ID: 23143980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bone marrow niche in support of breast cancer dormancy.
    Walker ND; Patel J; Munoz JL; Hu M; Guiro K; Sinha G; Rameshwar P
    Cancer Lett; 2016 Sep; 380(1):263-71. PubMed ID: 26546045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory Role of Quiescence in the Biological Function of Cancer Stem Cells.
    Lee SH; Reed-Newman T; Anant S; Ramasamy TS
    Stem Cell Rev Rep; 2020 Dec; 16(6):1185-1207. PubMed ID: 32894403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic Cell Dormancy and Re-activation: An Overview on Series of Molecular Events Critical for Cancer Relapse.
    Muzes G; Sipos F
    Anticancer Agents Med Chem; 2017; 17(4):472-482. PubMed ID: 27592547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention.
    Tamamouna V; Pavlou E; Neophytou CM; Papageorgis P; Costeas P
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic dormancy: a complex network between cancer stem cells and their microenvironment.
    Bleau AM; Agliano A; Larzabal L; de Aberasturi AL; Calvo A
    Histol Histopathol; 2014 Dec; 29(12):1499-510. PubMed ID: 24887025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unveiling cancer dormancy: Intrinsic mechanisms and extrinsic forces.
    Liu R; Zhao Y; Su S; Kwabil A; Njoku PC; Yu H; Li X
    Cancer Lett; 2024 Jun; 591():216899. PubMed ID: 38649107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
    Indraccolo S
    Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular dormancy in minimal residual disease following targeted therapy.
    Ruth JR; Pant DK; Pan TC; Seidel HE; Baksh SC; Keister BA; Singh R; Sterner CJ; Bakewell SJ; Moody SE; Belka GK; Chodosh LA
    Breast Cancer Res; 2021 Jun; 23(1):63. PubMed ID: 34088357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting autophagy in cancer stem cells as an anticancer therapy.
    Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
    Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic approaches targeting cancer stem cells.
    Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
    J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.